EyePoint Pharmaceuticals, Inc. Insider Transactions
EyePoint Pharmaceuticals, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
GUYER DAVID R
Director |
Sell | 11,625 @ $10.30 | $119,705 | 3,700 | 06/03/2024 | 06/04/2024 | |
|
GUYER DAVID R
Director |
Sell | 11,625 @ $12.65 | $147,045 | 5,550 | 05/14/2024 | 05/16/2024 | |
|
Cormorant Asset Management, LP
10 percent owner |
Buy | 207,153 @ $12.36 | $2.56 M | 8,325,000 | 05/06/2024 | 05/08/2024 | |
|
Cormorant Asset Management, LP
10 percent owner |
Buy | 642,847 @ $11.70 | $7.52 M | 8,117,847 | 05/06/2024 | 05/08/2024 | |
|
Cormorant Asset Management, LP
10 percent owner |
Buy | 395,244 @ $17.62 | $6.96 M | 7,288,479 | 04/18/2024 | 04/22/2024 | |
|
Cormorant Asset Management, LP
10 percent owner |
Buy | 186,521 @ $18.90 | $3.53 M | 7,475,000 | 04/18/2024 | 04/22/2024 | |
|
Jones David Scott
SVP & Chief Commercial Officer |
Sell | 209 @ $28.49 | $5,954 | 37,962 | 02/02/2024 | 02/05/2024 | |
|
Paggiarino Dario A.
Chief Medical Officer |
Sell | 51 @ $25.41 | $1,296 | 85,779 | 01/26/2024 | 01/30/2024 | |
|
Paggiarino Dario A.
Chief Medical Officer |
Sell | 15,609 @ $25.41 | $396,572 | 70,170 | 01/26/2024 | 01/30/2024 | |
|
Paggiarino Dario A.
Chief Medical Officer |
Sell | 33,665 @ $25.77 | $867,672 | 36,505 | 01/26/2024 | 01/30/2024 | |
|
Jones David Scott
SVP & Chief Commercial Officer |
Sell | 16,413 @ $25.45 | $417,653 | 47,566 | 01/26/2024 | 01/29/2024 | |
|
Jones David Scott
SVP & Chief Commercial Officer |
Sell | 9,604 @ $25.27 | $242,717 | 37,962 | 01/26/2024 | 01/29/2024 | |
|
Paggiarino Dario A.
Chief Medical Officer |
Sell | 300 @ $25.00 | $7,500 | 36,505 | 01/25/2024 | 01/29/2024 | |
|
Jones David Scott
SVP & Chief Commercial Officer |
Sell | 300 @ $25.00 | $7,500 | 37,962 | 01/25/2024 | 01/26/2024 | |
|
Jones David Scott
SVP & Chief Commercial Officer |
Sell | 5,700 @ $25.01 | $142,554 | 43,562 | 01/24/2024 | 01/26/2024 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
EyePoint Pharmaceuticals, Inc. FAQ's
The list of insiders at EyePoint Pharmaceuticals, Inc. includes Cormorant Asset Management, LP, GUYER DAVID R.
Insiders have sold a total of 23,250 EyePoint Pharmaceuticals, Inc. shares in the last 12 months for a total of 266,750 sold.
The following insiders have sold EyePoint Pharmaceuticals, Inc. shares in the last 12 months: GUYER DAVID R ($266,750),
Insiders have purchased a total of 1.43 M EyePoint Pharmaceuticals, Inc. shares in the last 12 months for a total of 20.57 M.
The following insiders have purchased EyePoint Pharmaceuticals, Inc. shares in the last 12 months: Cormorant Asset Management, LP ($20.57 M),